- B.S. Pharmacy, Chung-Ang University, Seoul, South Korea
- M.S. Pharmacy, Chung-Ang University, Seoul, South Korea
- Ph.D. University of Texas at Austin
Pharmacoeconomics and health policy research
Economic and health outcomes evaluation
Haesuk Park, Ph.D., is an Assistant Professor in the Department of Pharmaceutical Outcomes and Policy. She received her Bachelor and Master in Pharmacy from South Korea, and her Ph.D. at The University of Texas at Austin, College of Pharmacy, Health Outcomes & Pharmacy Practice. Her research centers on economic and health outcomes studies of medications and pharmaceutical care services as well as policy associated with the use of pharmaceuticals. She is passionate about investigating questions related to health policy in vulnerable populations and, particularly, how a policy affects access to care, the quality and cost of health care, and ultimately health outcomes. In recent years, the clinical focus of her research has centered on patients with hepatitis C virus (HCV) infection, a research area with growing intensity and breadth due to the increasing awareness of the disease burden and the continuing development of new treatments. She successfully obtained industry grants to develop cost-effectiveness models of new HCV therapies and conduct a meta-analysis of observational studies to examine the burden of disease. With a grant from Florida Department of Health, she also collaborated a project to evaluate the impact of a telephonic outreach program on medication adherence in Medicare beneficiaries.
She has published more than 20 peer-reviewed papers and several of which are published in high-impact journals (e.g., Gastroenterology, Hepatology). She has presented over 50 poster and podium presentations at national and international conferences. Her research has received a number of awards and recognition by the professional community such as the Best New Investigator Presentation Award at the International Society for Pharmaceutical Outcomes Research (ISPOR), Best Paper Award in the Economic, Social & Administrative Sciences at the American Pharmacists Association (APhA) Annual Meeting, and the University of Florida Excellence Award for Assistant Professors.
Park H, Chen C, Henry L, Wang W, Cook R, Nelson D. Hepatitis C Virus Infection Increases the Risk of Chronic Kidney Disease (CKD) while Effective HCV Treatment Decreases the Incidence of CKD. Hepatology 2017 DOI: 10.1002/hep.29505
Younossi Z, Park H, Dieterich D, Saab S, Ahmed A, Gordon S. The value of cure associated with treating treatment-naïve chronic hepatitis C genotype 1: Are the new all oral regimes good value to society? Liver International 2017;37(5):662-668
Park H, Adeyemi A, Wang W, Roane T. Impact of a telephonic outreach program on medication adherence in Medicare Prescription Drug (MAPD) Plan beneficiaries in Florida. Journal of the American Pharmacist Association (JAPHA) 2017; 57(1):62-66
Younossi Z, Park H, Henry L, Adeyemi A, Stepanova M. The extra-hepatic manifestations of hepatitis C – a meta-analysis of prevalence rates, effects on patient-reported outcomes economic burden. Gastroenterology 2016;150(7):1599-608
Full list of published work retrievable by PubMed: http://www.ncbi.nlm.nih.gov/sites/myncbi/1Fi2ensYbNxQd/bibliograpahy/40314061/public/?sort=date&direction=descending